Effect of enzalutamide on time to first skeletal-related event, pain, and quality of life in men with castration-resistant prostate cancer: Results from the randomised, phase 3 AFFIRM trial

Karim Fizazi*, Howard I. Scher, Kurt Miller, Ethan Basch, Cora N. Sternberg, David Cella, David Forer, Mohammad Hirmand, Johann S. de Bono

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

152 Scopus citations

Fingerprint

Dive into the research topics of 'Effect of enzalutamide on time to first skeletal-related event, pain, and quality of life in men with castration-resistant prostate cancer: Results from the randomised, phase 3 AFFIRM trial'. Together they form a unique fingerprint.

Medicine & Life Sciences